Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today provided an update on its drug candidate pipeline targeted to Toll-like Receptors during its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE